A detailed history of Cumberland Partners LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Cumberland Partners LTD holds 27,997 shares of ABBV stock, worth $4.9 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
27,997
Previous 42,847 34.66%
Holding current value
$4.9 Million
Previous $7.35 Million 24.78%
% of portfolio
0.42%
Previous 0.58%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$163.84 - $199.33 $2.43 Million - $2.96 Million
-14,850 Reduced 34.66%
27,997 $5.53 Million
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $2.23 Million - $2.6 Million
14,395 Added 50.59%
42,847 $7.35 Million
Q1 2024

May 09, 2024

BUY
$159.82 - $182.1 $4.55 Million - $5.18 Million
28,452 New
28,452 $5.18 Million
Q2 2023

Aug 09, 2023

BUY
$132.51 - $164.9 $1.93 Million - $2.4 Million
14,560 Added 255.35%
20,262 $2.73 Million
Q1 2023

May 08, 2023

SELL
$144.61 - $166.54 $4.45 Million - $5.13 Million
-30,790 Reduced 84.37%
5,702 $908,000
Q4 2022

Feb 06, 2023

SELL
$138.31 - $165.87 $2.35 Million - $2.82 Million
-16,980 Reduced 31.75%
36,492 $5.9 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $1.35 Million - $1.55 Million
10,085 Added 23.24%
53,472 $7.18 Million
Q2 2022

Aug 10, 2022

BUY
$137.62 - $174.96 $2.88 Million - $3.66 Million
20,925 Added 93.16%
43,387 $6.65 Million
Q1 2022

May 10, 2022

BUY
$131.98 - $163.75 $1.85 Million - $2.29 Million
14,012 Added 165.82%
22,462 $3.64 Million
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $907,783 - $1.15 Million
8,450 New
8,450 $1.14 Million
Q1 2019

May 15, 2019

SELL
$77.14 - $90.79 $539,980 - $635,530
-7,000 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $8,952 - $11,041
115 Added 1.67%
7,000 $645,000
Q3 2018

Nov 15, 2018

SELL
$88.91 - $98.84 $680,161 - $756,126
-7,650 Reduced 52.63%
6,885 $651,000
Q2 2018

Aug 09, 2018

BUY
$89.78 - $106.23 $1.3 Million - $1.54 Million
14,535 New
14,535 $1.35 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cumberland Partners LTD Portfolio

Follow Cumberland Partners LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cumberland Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Cumberland Partners LTD with notifications on news.